Products
Fees
Download
Promotions
Promotions
Welcome Rewards
Referral Program
US Pre-Market Options Trading
For Institutions
For Institutions
Corporate Services
Developers
Help
About
About
About Longbridge
License & Regulatory
Media Coverage
Join Us
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote List
Quote List
DRTG
(600329.SH)
Last Updated 00:00:00
News
Financials
Overview
Ultra-high dividend yield stocks exposed, 47 stocks with the latest dividend yield exceeding 5%
36Kr
·
04/03/2026 08:23
SH
600329
-3.18%
SH
600690
-0.48%
SZ
002763
-1.25%
36Kr
·
04/03/2026 08:23
SH
600329
-3.18%
SH
600690
-0.48%
SZ
002763
-1.25%
With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's "Special Regulations on the Registration of Traditional Chinese Medicine" is entering its final window period. This regulation, referred to in the industry as the "death clause" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibited
Wallstreetcn
·
01/27/2026 18:41
SH
512290
-0.11%
SZ
159929
-0.71%
SH
600436
-0.77%
Wallstreetcn
·
01/27/2026 18:41
SH
512290
-0.11%
SZ
159929
-0.71%
SH
600436
-0.77%
TJ DaRenTang announced its semi-annual performance, with a net profit attributable to the parent company of 1.928 billion yuan, a year-on-year increase of 193.08%
Zhitong
·
08/14/2025 16:31
SH
600329
-3.18%
SG
T14
+1.86%
Zhitong
·
08/14/2025 16:31
SH
600329
-3.18%
SG
T14
+1.86%
Some traditional Chinese medicine stocks saw their net profits double year-on-year in the first half of the year
Zhitong
·
08/01/2025 22:26
SH
600671
-0.16%
SH
600329
-3.18%
SZ
000623
-1.12%
Zhitong
·
08/01/2025 22:26
SH
600671
-0.16%
SH
600329
-3.18%
SZ
000623
-1.12%
TJ DaRenTang: Tongmai Yangxin Pills strongly recommended in the Traditional Chinese Medicine Diagnosis and Treatment Guidelines for Coronary Microvascular Disease
Zhitong
·
07/18/2025 22:17
SH
600329
-3.18%
SG
T14
+1.86%
Zhitong
·
07/18/2025 22:17
SH
600329
-3.18%
SG
T14
+1.86%
TJ DaRenTang: Expected net profit in the first half of 2025 to increase by 180%-204% year-on-year
Zhitong
·
07/14/2025 16:30
SH
600329
-3.18%
SG
T14
+1.86%
Zhitong
·
07/14/2025 16:30
SH
600329
-3.18%
SG
T14
+1.86%
DRTG deepens cooperation with Huawei
Zhitong
·
05/19/2025 08:50
SH
600329
-3.18%
Zhitong
·
05/19/2025 08:50
SH
600329
-3.18%
TJ DaRenTang announced its first-quarter performance, with a net profit attributable to the parent company of 374 million yuan, a year-on-year decrease of 3.38%
Zhitong
·
04/29/2025 22:21
SH
600329
-3.18%
SG
T14
+1.86%
Zhitong
·
04/29/2025 22:21
SH
600329
-3.18%
SG
T14
+1.86%
TJ DaRenTang plans to sell 12% of its shares in Tianjin Shike for 1.623 billion yuan to increase cash inflow
Zhitong
·
04/15/2025 17:34
SH
600329
-3.18%
SG
T14
+1.86%
Zhitong
·
04/15/2025 17:34
SH
600329
-3.18%
SG
T14
+1.86%
DRTG conducts in-depth cooperation and exchange with Guangdong Provincial Hospital of Traditional Chinese Medicine
Zhitong
·
04/04/2025 22:32
SH
600329
-3.18%
Zhitong
·
04/04/2025 22:32
SH
600329
-3.18%